We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Magnetic Nanoparticles Kill Tumors with Localized Heat

By LabMedica International staff writers
Posted on 25 Aug 2010
Magnetic nanoparticles coated with tumor specific antibodies have been used to detect tumors by thermographic imaging and destroy them by localized heating without damaging surrounding normal tissues.

Investigators at Tel Aviv University (Israel) conducted experiments using an in vitro tissue model, an inductive heating system, and an infrared camera. More...
The thermal images, recorded by the infrared camera, were analyzed using an algorithm that was developed as part of the work.

Results published in the July 8, 2010, online edition of the journal Nanomedicine showed that small tumor phantoms (diameter of 0.5 mm) that were embedded under the surface of the tissue phantom (up to 14 mm below the surface) could be detected and located.

By coating the nanoparticles with antibodies directed at specific tumors, it was possible to administer them through the blood with subsequent concentration at the site of the tumor.

"Once the nanoparticles bind to the tumor, we excite them with an external magnetic field, and they begin to heat very specifically and locally,” explained senior author Dr. Israel Gannot, professor of biomedical engineering at Tel Aviv University. "The magnetic field is manipulated to create a targeted rise in temperature, and it is this directed heat elevation which kills the tumors.”

The U.S. Food and Drugs Administration (FDA)-approved nanoparticles are readily excreted from the body and they cause little or no damage to normal tissues.

Related Links:
Tel Aviv University



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Hematology Consumables
Bioblood Devices
New
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The method that profiles DNA methylation in cell-free DNA from a single blood sample to detect disease signals system-wide (photo courtesy of Shutterstock)

cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample

Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read more

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.